WORKSHOP
Wednesday 24^th April 2019 | 09:00 - 12:30 | PETIT AMPHITHEATRE - Level 0

Chair : Deniz SECKIN (Turkey)

• Welcome and introduction
  Deniz SECKIN (Turkey)
• Melanoma in the context of organ transplantation: current issues and future outlooks
  Christoph HOELLER (Austria), Alexandra GEUSAU (Austria)
• Challenges for immunotherapy of Merkel cell carcinoma in organ transplant patients (including Q&A)
  Jurgen BECKER (Germany)
• Posttransplant Merkel cell carcinoma: what are the challenges and what does the SCOPE experience tell us?
  Carla FERRÁNDIZ-PULIDO (Spain)
• Tumor board: Case 1, Case 2 and Case 3
• Coffee break
• Management of the posttransplant advanced and high-stage cutaneous SCC: What are the difficulties, challenges and solutions? (including Q&A)
  Chrysalyne SCHMULTS (United States)
• Closing remarks and future perspectives
  Charlotte PROBY (United Kingdom)

WORKSHOP
Wednesday 24^th April 2019 | 13:30 - 14:45 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Céleste LEBBE (France), Claus GARBE (Germany), Jean-Jacques GROB (France)

• Prevention campaign will prevent skin cancer - Yes
  Alexander STRATIGOS (Greece)
• Prevention campaign will prevent skin cancer - No
  Claus GARBE (Germany)
• Will lymph node surgery remain a main therapy in melanoma? - Yes
  David MORENO-RAMIREZ (Spain)
• Will lymph node surgery remain a main therapy in melanoma? - No
  Axel HAUSCHILD (Germany)
• Adjuvant therapy should be moved to primary melanoma stage II - Yes
  Jean-Jacques GROB (France)
• Adjuvant therapy should be moved to primary melanoma stage II - No
  Paul LORIGAN (United Kingdom)

WORKSHOP
Wednesday 24^th April 2019 | 14:45 - 16:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Brigitte DRENO (France), Ketty PERIS (Italy), Alexander STRATIGOS (Greece)

• We should routinely measure quality of life of advanced melanoma patients - Yes
  Jessica HASSEL (Germany)
• We should routinely measure quality of life of advanced melanoma patients - No
  Isabelle BORGET (France)
• Tumor mutational burden (TMB) will guide our future systemic treatments - Yes
  Selma UGUREL (Germany)
• Tumor mutational burden (TMB) will guide our future systemic treatments - No
  Olivier MICHIELIN (Switzerland)
• Treatment of advanced melanoma: combining or sequencing? - Combining
  Paolo ASCIERTO (Italy)
• Treatment of advanced melanoma: combining or sequencing? - Sequencing
  Dirk SCHADENDORF (Germany)

PLENARY SESSION
Wednesday 24^th April 2019 | 17:30 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1

• Welcome address
  Céleste LEBBE (France), Claus GARBE (Germany), Abdellatif TAZI (to be confirmed)
• New developments in occupational skin cancer: WHO disease burden project and implications for our patients
  Swen Malte JOHN (Germany)

PLENARY SESSION
Wednesday 24^th April 2019 | 18:00 - 19:00 | AMPHITHEATRE LAVOISIER - Level 1

• New developments in occupational skin cancer: WHO disease burden project and implications for our patients
  Swen Malte JOHN (Germany)
• The long journey from melanocyte to melanoma
  Boris BASTIAN (United States)
• Targeting innate immunity in cancer treatment
  Eric VIVIER (France)
• Raising the efficacy in immunotherapy of melanoma: what are we going to achieve?
  Jennifer WARGO (United States)

WORKSHOP
Thursday 25^th April 2019 | 08:30 - 09:30 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Paolo ASCIERTO (Italy), Thomas GAJEWSKI (United States), Caroline ROBERT (France)

• Combining or sequencing targeted therapy and immunotherapy
  Paolo ASCIERTO (Italy)
• How to overcome primary and secondary resistance to immune checkpoint inhibitor
  Thomas GAJEWSKI (United States)
• How should we evaluate our patients in the era of immunotherapy? irRECIST, irRC, iRECIST?
  Caroline ROBERT (France)

WORKSHOP
Thursday 25^th April 2019 | 08:30 - 10:30 | PETIT AMPHITHEATRE - Level 0

Chair : Petr ARENBERGER (Czech Republic), Boris BASTIAN (United States), Maxime BATTISTELLA (France), Matilda Bylaitė-Bučinskienė (Lithuania), Arnaud DE LA FOUCHARDIERE (France), Judit OLAH (Hungary)

• Adnexal Tumors
  Maxime BATTISTELLA (France)
• MELTUMP
  Arnaud DE LA FOUCHARDIERE (France)
• Neoplastic disorders of the nipple
  Erika VARGA (Hungary)
• Borderline vascular tumors
  Matilda Bylaitė-Bučinskienė (Lithuania)
• Soft tissue tumors
  Judit OLAH (Hungary)
• Overview on rare skin tumors
  Petr ARENBERGER (Czech Republic)

WORKSHOP
Thursday 25^th April 2019 | 09:00 - 10:30 | ROOM 151 - Level 1

Chair : Martine BAGOT (France), Julia SCARISBRICK (United Kingdom), Rudolf STADLER (Germany)

• Tumor clone frequency is a robust predictor of progression and survival in patients with early stage mycosis fungoides
  Adèle DE MASSON (France)
• International landscape of therapies in CTCL, Results of the PROCLIPI Study
  Pietro QUAGLINO (Italy)
• Therapeutic Strategies for improved management in CTCL
  Rudolf STADLER (Germany)
• New monoclonal antibodies for the treatment of CTCL
  Martine BAGOT (France)
• Clinical endpoints updates and considerations for future staging
  Julia SCARISBRICK (United Kingdom)
• Management of Cutaneous B cell lymphoma
  Antonio COZZIO (Switzerland)

WORKSHOP
Thursday 25^th April 2019 | 09:30 - 10:30 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Axel HAUSCHILD (Germany), Jean-Jacques GROB (France), Nicolas MEYER (France)

• Stage II
  Jean-Jacques GROB (France)
• Stage III
  Axel HAUSCHILD (Germany)
• Stage IV
  Nicolas MEYER (France)

WORKSHOP
Thursday 25^th April 2019 | 11:00 - 12:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Sara GANDINI (Italy), Claus GARBE (Germany), David WHITEMAN (Australia)

• Incidence of melanoma in Europe 1950 - 2030
  Claus GARBE (Germany)
• Which percentage of melanoma is caused by UV radiation, and what proportion could be prevented?
  David WHITEMAN (Australia)
• Nevi and melanoma: who, when and how?
  Sara GANDINI (Italy)
• What do we achieve with screening examinations?
  Andreas STANG (Germany)

WORKSHOP
Thursday 25^th April 2019 | 11:00 - 12:00 | PETIT AMPHITHEATRE - Level 0

Chair : John HAANEN (Netherlands), Olivier MICHIELIN (Switzerland), Selma UGUREL (Germany)

• Biomarkers in melanoma, an overview
  Olivier MICHIELIN (Switzerland)
• Circulating cytokines and immune related toxicity
  Jenny LEE (Austria)
• Microbiome
  Beth HELMINK (United States)
• Single cell RNA seq of immune infiltrates
  To be confirmed

WORKSHOP
Thursday 25^th April 2019 | 11:00 - 12:00 | ROOM 151 - Level 1

Chair : Barouyr BAROUDJIAN (France), Lucie HEINZERLING (Germany), Christoph HOELLER (Austria)

• A case of Myositis
  Lucie HEINZERLING (Germany)
• Myocarditis: what clinicians should know
  Dimitri ARANGALAGE (France)
• An unusual Hematologic side effect
  Erwin STRASSER (Germany)
• Immune related hepatitis: can we resume the treatment ?
  Olivier ROUX (France)
• Beware of rare endocrinologic immune related adverse events
  Florence BRUNET-POSSENTI (France)

PLENARY SESSION
Thursday 25^th April 2019 | 12:00 - 13:00 | AMPHITHEATRE LAVOISIER - Level 1

• Where and when will melanoma incidence decrease?
  David WHITEMAN (Australia)
• How to modulate tumor microenvironment?
  Thomas GAJEWSKI (United States)
• Molecular resistance to targeted therapy, from bench to bedside
  Grant MCARTHUR (Australia)

WORKSHOP
Thursday 25^th April 2019 | 14:00 - 15:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Véronique DEL MARMOL (Belgium), Ana Maria FORSEA (Romania), Eduardo NAGORE (Spain)

• UVR and cellular damage: implications for skin cancer prevention
  Amaya VIROS (United Kingdom)
• Melanoma risk and sunbeds use – time to close the debate
  Mariano SUPPA (Belgium)
• Prevention according to different clinical profile
  Eduardo NAGORE (Spain)
• Skin cancer Chemoprevention - current evidence
  Ana Maria FORSEA (Romania)

WORKSHOP
Thursday 25^th April 2019 | 14:00 - 15:00 | ROOM 151 - Level 1

Chair : Ketty PERIS (Italy), Eggert STOCKFLETH (Germany), Nicole KELLENERS-SMEETS (Netherlands)

• Biology of AK
  Eggert STOCKFLETH (Germany)
• Diagnosis of AK
  Caterina LONGO
• Field directed treatments
  Nicole KELLENERS-SMEETS (Netherlands)
• AK treatment in organ transplant recipients
  Ketty PERIS (Italy)

FREE COMMUNICATIONS
Thursday 25^th April 2019 | 14:00 - 15:00 | PETIT AMPHITHEATRE - Level 0

Chair : Sophie DALAC-RAT (France), Lionel LARUE (France), Charlotte PROBY (United Kingdom), Dimitris SGOUROS (Greece)

WORKSHOP
Thursday 25^th April 2019 | 16:30 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Christoph HOELLER (Austria), Ricardo VIEIRA (Portugal), Philippe SAIAG (France)

• Radiotherapy
  Philippe SAIAG (France)
• Intralesional injections
  Christoph HOELLER (Austria)
• Other local treatments
  Ricardo VIEIRA (Portugal)

WORKSHOP
Thursday 25^th April 2019 | 16:30 - 18:00 | ROOM 151 - Level 1

Chair : Emilie LE RHUN (France), Friedegund MEIER (Germany), Hussein TAWBI (United States)

• Diagnosis and local treatment of CNS metastasis: surgery and radiotherapy
  Michael WELLER (Switzerland)
• Targeted therapy alone or in combination with RT in melanoma CNS metastases
  Friedegund MEIER (Germany)
• Immunotherapy alone or in combination with RT in melanoma CNS metastases
  Hussein TAWBI (United States)
• Challenges in the design of CNS metastases trials
  Emilie LE RHUN (France)

FREE COMMUNICATIONS
Thursday 25^th April 2019 | 16:30 - 18:00 | PETIT AMPHITHEATRE - Level 0

Chair : Stéphane DALLE (France), Helen GOGAS (Greece), Janice MEHNERT (United States)

WORKSHOP
Friday 26^th April 2019 | 08:30 - 09:30 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Christian BLANK (Netherlands), James LARKIN (United Kingdom), Peter MOHR (Germany)

• Neoadjuvant immunotherapy in melanoma
  Christian BLANK (Netherlands)
• Neoadjuvant targeted therapy in melanoma
  Peter MOHR (Germany)
• Neoadjuvant therapy and lessons from other tumor types and lessons to learn from former neoadjuvant trials in melanoma
  James LARKIN (United Kingdom)

WORKSHOP
Friday 26^th April 2019 | 08:30 - 09:30 | ROOM 151 - Level 1

Chair : Giovanni PELLACANI (Italy), Luc THOMAS (France), Iris ZALAUDEK (Austria)

• How dermoscopy improves differential diagnosis of melanoma
  Luc THOMAS (France)
• How confocal microscopy improves management decisions
  Giovanni PELLACANI (Italy)
• When instruments are not enough, clinical clues are needed
  Aimilios LALLAS (Greece)
• Questions & Answers

WORKSHOP
Friday 26^th April 2019 | 08:30 - 10:30 | PETIT AMPHITHEATRE - Level 0

Chair : Claus GARBE (Germany), Lidija KANDOLF-SEKULOVIC (Serbia and Montenegro), Dirk SCHADENDORF (Germany), Lise BOUSSEMART (France)

• The optimal melanoma care pathway - the European perspective
  Lidija KANDOLF-SEKULOVIC (Serbia and Montenegro)
• The system of quality assurance of skin cancer centers in Germany
  Claus GARBE (Germany)
• Biobanking in skin cancer centers
  Dirk SCHADENDORF (Germany)
• Translational research in a skin cancer center: when advances in next generation sequencing serve melanoma patients' care
  Lise BOUSSEMART (France)
• E-health data and their role in skin cancer patient management
  Thomas EIGENTLER (Germany)
• Discussion

WORKSHOP
Friday 26^th April 2019 | 09:30 - 10:30 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Florence CORGIBET (France), Roland KAUFMANN (Germany), Vernon SONDAK (United States)

• Before and after surgical procedures
  Florence CORGIBET (France)
• Surgical procedures for the primary tumour
  Roland KAUFMANN (Germany)
• About the sentinel node biopsies and nodal dissections
  Vernon SONDAK (United States)

WORKSHOP
Friday 26^th April 2019 | 09:30 - 10:30 | ROOM 151 - Level 1

Chair : Véronique DEL MARMOL (Belgium), Josep MALVEHY (Spain), Nesrine BRAHIMI (France)

• High definition Ultrasound and skin cancer diagnosis approach
  Philippe BAHADORAN (France)
• LC OCT : A new definition for Optical coherence tomography to diagnose skin cancer
  Mariano SUPPA (Belgium)
• Early skin cancer detection and follow up using polarized dynamic speckle
  Xavier ORLIK (France)
• Ex vivo confocal microscopy a new approach for skin cancer margins  
  Josep MALVEHY (Spain)

WORKSHOP
Friday 26^th April 2019 | 10:30 - 12:00 | PETIT AMPHITHEATRE - Level 0

Chair : Nicole BASSET-SEGUIN (France), Ulrike LEITER (Germany), Michael MIGDEN (United States)

• General principles of management of NMSC
  Alexander STRATIGOS (Greece)
• Surgery in advanced tumors (SCC and BCC)
  David MORENO-RAMIREZ (Spain)
• Systemic treatment of advanced BCC
  Nicole BASSET-SEGUIN (France)
• Systemic Treatment of advanced SCC
  Ulrike LEITER (Germany)
• Expert Panel discussion                                          
  David MORENO-RAMIREZ (Spain)
• Expert Panel discussion
  Alexander STRATIGOS (Greece)
• Expert Panel discussion                                          
  Nicole BASSET-SEGUIN (France)
• Expert panel discussion: Difficult to treat BCC- challenging cases
  Matilda Bylaitė-Bučinskienė (Lithuania)
• Expert panel discussion: Difficult to treat SCC- challenging cases
  Ingrid WOLF (Austria)

WORKSHOP
Friday 26^th April 2019 | 11:00 - 12:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Brigitte DRENO (France), Grant MCARTHUR (Australia), Jessica HASSEL (Germany)

WORKSHOP
Friday 26^th April 2019 | 11:00 - 12:00 | ROOM 151 - Level 1

Chair : Emilie DUCROUX (France), Catherine HARWOOD (United Kingdom), Deniz SECKIN (Turkey)

• Introduction
  Deniz SECKIN (Turkey)
• What is new in the pathogenesis and treatment of posttransplant Kaposi's sarcoma?
  Stéphane BARETE (France)
• The role and therapeutic implications of HPV presence in posttransplant squamous cell carcinoma: SCOPE research update
  Jan Nico BOUWES-BAVINCK (Netherlands)
• Skin field cancerization: Converging transcription/ epigenetic regulatory pathways of translational value
  Paolo DOTTO (Switzerland)

PLENARY SESSION
Friday 26^th April 2019 | 12:00 - 13:00 | AMPHITHEATRE LAVOISIER - Level 1

• Biology and therapy of Merkel cell carcinoma
  Paul NGHIEM (United States)
• Targeting pathways in basal cell carcinoma: sonic hedgehog and beyond
  Nicole BASSET-SEGUIN (France)

WORKSHOP
Friday 26^th April 2019 | 14:00 - 15:30 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Boris BASTIAN (United States), Nicolas DUMAZ (France), Amaya VIROS (United Kingdom)

• Nongenetic mechanisms as drivers of tumor evolution and therapy resistance
  Jean-Christophe MARINE (Belgium)
• TERT promoter mutations, telomere length and melanoma survival and risk
  Rajive KUMAR (Germany)
• Novel roles of ROCK-Myosin II in melanoma
  Victoria SANZ-MORENO (United Kingdom)
• Neural Crest Stemness in Melanoma
  Lukas SOMMER (Switzerland)

WORKSHOP
Friday 26^th April 2019 | 14:00 - 15:30 | ROOM 151 - Level 1

Chair : Jurgen BECKER (Germany), Nicolas DUPIN (France), Paul NGHIEM (United States)

• Immunobiology of Merkel cell carcinoma
  Jurgen BECKER (Germany)
• Progress and challenges in Merkel cell carcinoma management
  Paul NGHIEM (United States)
• Update on oncogenesis and therapy for Kaposi’s sarcoma
  Nicolas DUPIN (France)

FREE COMMUNICATIONS
Friday 26^th April 2019 | 14:00 - 15:30 | PETIT AMPHITHEATRE - Level 0

Chair : Ralf GUTZMER (Germany), Gaëlle QUEREUX (France), Henri MONTAUDIE (France), Emmanuella GUENOVA (Switzerland)

WORKSHOP
Friday 26^th April 2019 | 17:00 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Irene LEIGH (United Kingdom), Dany NASSAR (France), Chrysalyne SCHMULTS (United States)

• Mechanisms of Resistance to Hedgehog/Smoothened Inhibitors in BCC
  Michael MIGDEN (United States)
• Regulation of Epithelial Mesenchymal Transition in SCC
  Dany NASSAR (France)
• Squamous Carcinogenesis: Commonalities and Difference Across Epithelial Cell Types
  Catherine HARWOOD (United Kingdom)
• Molecular Prediction of Recurrence and Metastasis in SCC
  Chrysalyne SCHMULTS (United States)

WORKSHOP
Friday 26^th April 2019 | 17:00 - 18:00 | ROOM 151 - Level 1

Chair : Susanna PUIG (Spain), Pierre VABRES (France), Pierre WOLKENSTEIN (France)

• Genetics of basal cell carcinoma
  Asma SMAHI (France)
• Genetics of familial melanoma
  Susanna PUIG (Spain)
• Neurofibromatosis 1 and related tumours
  Pierre WOLKENSTEIN (France)
• Genetic disorders of the PIK3CA/PTEN/MTOR pathway
  Pierre VABRES (France)

FREE COMMUNICATIONS
Friday 26^th April 2019 | 17:00 - 18:30 | PETIT AMPHITHEATRE - Level 0

Chair : Véronique BATAILLE (United Kingdom), Julie DELYON (France), Caroline GAUDY (France), Emmanuella GUENOVA (Switzerland)

WORKSHOP
Saturday 27^th April 2019 | 08:30 - 09:30 | ROOM 151 - Level 1

Chair : Philippe BAHADORAN (France), Ralph BRAUN (Switzerland), Josep MALVEHY (Spain)

• When confocal is of help 
  Caterina LONGO
• When dermoscopy is not straight forward
  Mona AMINI-ADLER (France)
• Basal cell carcinoma (dermoscopy, OCT and confocal),
  Mariano SUPPA (Belgium)
• Pre- and intra-operative use of non-invasive techniques
  Susanna PUIG (Spain)

WORKSHOP
Saturday 27^th April 2019 | 08:30 - 11:00 | AMPHITHEATRE LAVOISIER - Level 1

Chair : Jean-Jacques GROB (France), Eve MAUBEC (France), Chrysalyne SCHMULTS (United States), Victor FARRICHA (Portugal)

• Advanced SCC arising in hidradenitis suppurativa
  Eve MAUBEC (France)
• Multiple scalp SCCs in a patient with chronic lymphocytic leukemia
  Chrysalyne SCHMULTS (United States)
• Rapid growth of SCC while on JAK inhibitor for myelofibrosis
  Victor FARRICHA (Portugal)
• What is a difficult to treat BCC?”
  Jean-Jacques GROB (France)
• A young patient with sarcoidosis and voriconazole-induced locally advanced SCC
  Eve MAUBEC (France)
• A renal transplant patient with multiply recurrent SCC. Is anti PD-1 treatment ever appropriate in transplant patients
  Chrysalyne SCHMULTS (United States)

WORKSHOP
Saturday 27^th April 2019 | 09:30 - 10:30 | ROOM 151 - Level 1

Chair : Harald KITTLER (Austria), Aimilios LALLAS (Greece), Iris ZALAUDEK (Austria)

• When dermoscopy is straight forward
  Aimilios LALLAS (Greece)
• When dermoscopy is not straight forward
  Harald KITTLER (Austria)
• When confocal is of help
  Caterina LONGO
• Pre- and intra-operative use of non-invasive techniques
  Susanna PUIG (Spain)

PLENARY SESSION
Saturday 27^th April 2019 | 11:30 - 12:30 | AMPHITHEATRE LAVOISIER - Level 1

• What's new in non melanoma skin cancer?
  Brigitte DRENO (France)
• What's new in melanoma?
  Olivier MICHIELIN (Switzerland)
• What's new in cutaneous lymphoma?
  Marie BEYLOT-BARRY (France)